Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8954765rdf:typepubmed:Citationlld:pubmed
pubmed-article:8954765lifeskim:mentionsumls-concept:C0162641lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0162642lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0002844lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0042896lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8954765lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8954765pubmed:issue3lld:pubmed
pubmed-article:8954765pubmed:dateCreated1997-3-10lld:pubmed
pubmed-article:8954765pubmed:abstractTextTreatment of mature female tilapia (Oreochromis niloticus) with high levels of androgen (17 alpha-methyltestosterone, 17 alpha MT) results in a pronounced decline in plasma vitellogenin levels as determined by gel electrophoresis. Total RNA extracted from livers of treated fish and vehicle-injected controls was analyzed by Northern and slot blot hybridization using an oligonucleotide complementary to a sequence in the 3' end of tilapia vitellogenin mRNA. The probe revealed an mRNA of 6.5 kb in liver from the control mature female fish which was decreased by 85% by androgen treatment. As expected, estradiol (E2) treatment induced the 6.5-kb mRNA in mature male tilapia. The antiestrogen, tamoxifen, strongly decreased vitellogenin mRNA levels in mature females. Radioimmunoassay of serum from control and 17 alpha MT-treated female tilapia showed a marked reduction in serum E2 levels, from 11.4 +/- 2.6 ng/ml in controls to 2.2 +/- 0.13 ng/ml in treated fish. Tamoxifen, however, resulted in increased serum E2 levels, probably by blocking E2 negative feedback. The serum E2-lowering effect of 17 alpha MT suggests an inhibitory site of action on gonadotropin production at the hypothalamic-pituitary axis, possibly through an androgen receptor or through an estrogen receptor after local aromatization of 17 alpha MT.lld:pubmed
pubmed-article:8954765pubmed:languageenglld:pubmed
pubmed-article:8954765pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:citationSubsetIMlld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8954765pubmed:statusMEDLINElld:pubmed
pubmed-article:8954765pubmed:monthDeclld:pubmed
pubmed-article:8954765pubmed:issn0016-6480lld:pubmed
pubmed-article:8954765pubmed:authorpubmed-author:WrightJ MJMlld:pubmed
pubmed-article:8954765pubmed:authorpubmed-author:LazierC BCBlld:pubmed
pubmed-article:8954765pubmed:authorpubmed-author:LangleySSlld:pubmed
pubmed-article:8954765pubmed:authorpubmed-author:RamseyN BNBlld:pubmed
pubmed-article:8954765pubmed:issnTypePrintlld:pubmed
pubmed-article:8954765pubmed:volume104lld:pubmed
pubmed-article:8954765pubmed:ownerNLMlld:pubmed
pubmed-article:8954765pubmed:authorsCompleteYlld:pubmed
pubmed-article:8954765pubmed:pagination321-9lld:pubmed
pubmed-article:8954765pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:meshHeadingpubmed-meshheading:8954765-...lld:pubmed
pubmed-article:8954765pubmed:year1996lld:pubmed
pubmed-article:8954765pubmed:articleTitleAndrogen inhibition of vitellogenin gene expression in tilapia (Oreochromis niloticus).lld:pubmed
pubmed-article:8954765pubmed:affiliationDepartment of Biochemistry, Dalhousie University, Halifax, Nova Scotia, Canada. CBLAZIE@AC.DAL.CAlld:pubmed
pubmed-article:8954765pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8954765pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed